Estadísticas de Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced non-small cell lung cancer: the PROLUNG Phase 2 randomized clinical trial

Visitas totales

views
Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced non-small cell lung cancer: the PROLUNG Phase 2 randomized clinical trial 0

Visitas totales por mes

views
mayo 2024 0
junio 2024 0
julio 2024 0
agosto 2024 0
septiembre 2024 0
octubre 2024 0
noviembre 2024 0